Elopag 50 mg (Eltrombopag) is a thrombopoietin receptor agonist used for chronic immune thrombocytopenia, aplastic anemia, and hepatitis C–related low platelets. It stimulates platelet production in the bone marrow. Common side effects include liver enzyme elevation, nausea, and fatigue. Requires monitoring. https://oncologymedi.com/product/elopag-50-mg-eltrombopag/